Clinical Trial

Predictive Value of aEEG and Cerebral Oxygenation on Neurological Outcomes in Newborns With Mild Hypoxic-Ischemic Encephalopathy

Recruiting
View on ClinicalTrials.gov →
Summary
Newborns with mild hypoxic-ischemic encephalopathy usually do not receive cooling treatment. However, some of these newborns may develop neurological problems later in life. This observational study aims to evaluate whether early brain monitoring and measurements of brain oxygen levels are associated with neurological outcomes in newborns with mild hypoxic-ischemic encephalopathy. Newborns will be monitored during the first 72 hours after birth as part of routine clinical care. Neurological assessments will be performed during early infancy and later follow-up. The findings of this study may help improve early risk assessment and support closer monitoring of newborns who may be at increased risk for unfavorable neurological outcomes.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-02
Trial Details
NCT Number NCT07393620
Lead Sponsor Uludag University
Conditions Hypoxic-Ischemic Encephalopathy Mild
Enrollment 30 participants
Start Date 2026-02-10
Primary Completion 2027-02-10 (estimated)
Study Completion 2029-02-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-01